688 related articles for article (PubMed ID: 28971272)
1. Monocyte and macrophage immunometabolism in atherosclerosis.
Groh L; Keating ST; Joosten LAB; Netea MG; Riksen NP
Semin Immunopathol; 2018 Feb; 40(2):203-214. PubMed ID: 28971272
[TBL] [Abstract][Full Text] [Related]
2. Immunometabolism orchestrates training of innate immunity in atherosclerosis.
van Tuijl J; Joosten LAB; Netea MG; Bekkering S; Riksen NP
Cardiovasc Res; 2019 Jul; 115(9):1416-1424. PubMed ID: 31050710
[TBL] [Abstract][Full Text] [Related]
3. Innate Immune Memory in Monocytes and Macrophages: The Potential Therapeutic Strategies for Atherosclerosis.
Guo Z; Wang L; Liu H; Xie Y
Cells; 2022 Dec; 11(24):. PubMed ID: 36552836
[TBL] [Abstract][Full Text] [Related]
4. Trained Immunity in Atherosclerotic Cardiovascular Disease.
Flores-Gomez D; Bekkering S; Netea MG; Riksen NP
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):62-69. PubMed ID: 33147995
[TBL] [Abstract][Full Text] [Related]
5. From metabolic to epigenetic: Insight into trained macrophages in atherosclerosis (Review).
Li T; Feng W; Yan W; Wang T
Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38904193
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria in monocytes and macrophages-implications for translational and basic research.
Ravi S; Mitchell T; Kramer P; Chacko B; Darley-Usmar VM
Int J Biochem Cell Biol; 2014 Aug; 53():202-207. PubMed ID: 24863362
[TBL] [Abstract][Full Text] [Related]
7. The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis.
Bekkering S; Joosten LA; van der Meer JW; Netea MG; Riksen NP
Clin Ther; 2015 Apr; 37(4):914-23. PubMed ID: 25704108
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-Macrophages and T Cells in Atherosclerosis.
Tabas I; Lichtman AH
Immunity; 2017 Oct; 47(4):621-634. PubMed ID: 29045897
[TBL] [Abstract][Full Text] [Related]
9. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.
Fraser DA; Tenner AJ
J Immunol; 2010 Oct; 185(7):3932-9. PubMed ID: 20833838
[TBL] [Abstract][Full Text] [Related]
10. Metabolism: The road to inflammation and atherosclerosis.
Ali L; Schnitzler JG; Kroon J
Curr Opin Lipidol; 2018 Dec; 29(6):474-480. PubMed ID: 30234554
[TBL] [Abstract][Full Text] [Related]
11. Macrophage: A Key Therapeutic Target in Atherosclerosis?
Taghizadeh E; Taheri F; Renani PG; Reiner Ž; Navashenaq JG; Sahebkar A
Curr Pharm Des; 2019; 25(29):3165-3174. PubMed ID: 31470780
[TBL] [Abstract][Full Text] [Related]
12. Trained immunity and atherosclerotic cardiovascular disease.
Riksen NP
Curr Opin Lipidol; 2019 Oct; 30(5):395-400. PubMed ID: 31335332
[TBL] [Abstract][Full Text] [Related]
13. Regulation of macrophage function in inflammation and atherosclerosis.
Shibata N; Glass CK
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S277-81. PubMed ID: 18987388
[TBL] [Abstract][Full Text] [Related]
14. Regulation of macrophage immunometabolism in atherosclerosis.
Koelwyn GJ; Corr EM; Erbay E; Moore KJ
Nat Immunol; 2018 Jun; 19(6):526-537. PubMed ID: 29777212
[TBL] [Abstract][Full Text] [Related]
15. Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.
Ketelhuth DFJ; Lutgens E; Bäck M; Binder CJ; Van den Bossche J; Daniel C; Dumitriu IE; Hoefer I; Libby P; O'Neill L; Weber C; Evans PC
Cardiovasc Res; 2019 Jul; 115(9):1385-1392. PubMed ID: 31228191
[TBL] [Abstract][Full Text] [Related]
16. Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis.
Leentjens J; Bekkering S; Joosten LAB; Netea MG; Burgner DP; Riksen NP
Circ Res; 2018 Mar; 122(5):664-669. PubMed ID: 29367213
[TBL] [Abstract][Full Text] [Related]
17. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
McLaren JE; Michael DR; Ashlin TG; Ramji DP
Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
[TBL] [Abstract][Full Text] [Related]
18. Immunometabolic control of trained immunity.
Riksen NP; Netea MG
Mol Aspects Med; 2021 Feb; 77():100897. PubMed ID: 32891423
[TBL] [Abstract][Full Text] [Related]
19. Trained immunity and diabetic vascular disease.
Thiem K; Stienstra R; Riksen NP; Keating ST
Clin Sci (Lond); 2019 Jan; 133(2):195-203. PubMed ID: 30659160
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics and Trained Immunity.
van der Heijden CDCC; Noz MP; Joosten LAB; Netea MG; Riksen NP; Keating ST
Antioxid Redox Signal; 2018 Oct; 29(11):1023-1040. PubMed ID: 28978221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
